Pasar al contenido principal

REPRESION TRANSCRIPCIONAL EN EL DESARROLLO DE DROSOPHILA

PID2020-119248GB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cross-species analysis of LZTR1 loss-of-function mutants demonstrates dependency to RIT1 orthologs

  • Cuevas-Navarro, Antonio
  • Rodríguez-Muñoz, Laura
  • Grego-Bessa, Joaquim
  • Cheng, Alice
  • Rauen, Katherine A
  • Urisman, Anatoly
  • McCormick, Frank
  • Jiménez, Gerardo
  • Castel, Pau
RAS GTPases are highly conserved proteins involved in the regulation of mitogenic signaling. We have previously described a novel Cullin 3 RING E3 ubiquitin ligase complex formed by the substrate adaptor protein LZTR1 that binds, ubiquitinates, and promotes proteasomal degradation of the RAS GTPase RIT1. In addition, others have described that this complex is also responsible for the ubiquitination of classical RAS GTPases. Here, we have analyzed the phenotypes of Lztr1 loss-of-function mutants in both fruit flies and mice and have demonstrated a biochemical preference for their RIT1 orthologs. Moreover, we show that Lztr1 is haplosufficient in mice and that embryonic lethality of the homozygous null allele can be rescued by deletion of Rit1. Overall, our results indicate that, in model organisms, RIT1 orthologs are the preferred substrates of LZTR1., This work was supported by the NCI (1F31CA265066 to AC-N), (R35CA197709 to FM), (K99CA245122 to PC) and the Department of Defense Neurofibromatosis Research Program (W81XWH-20-1-0391 to PC). We thank the UCSF Mass Spectrometry Facility and A L Burlingame for providing MS instrumentation support for this project (funded by the NIH grants P41GM103481 and S10OD016229). GJ and LR-M were funded by grants from the Spanish Government (BFU2017-87244-P, PID2020-119248GB-I00 and Predoctoral contract BES-2015–071486).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Noncanonical function of Capicua as a growth termination signal in Drosophila oogenesis

  • Rodríguez-Muñoz, Laura
  • Lagares, Clàudia
  • González-Crespo, Sergio
  • Castel, Pau
  • Veraksa, Alexey
  • Jiménez, Gerardo
Capicua (Cic) proteins are conserved HMG-box transcriptional repressors that control receptor tyrosine kinase (RTK) signaling responses and are implicated in human neurological syndromes and cancer. While Cic is known to exist as short (Cic-S) and long (Cic-L) isoforms with identical HMG-box and associated core regions but distinct N termini, most previous studies have focused on Cic-S, leaving the function of Cic-L unexplored. Here we show that Cic-L acts in two capacities during Drosophila oogenesis: 1) as a canonical sensor of RTK signaling in somatic follicle cells, and 2) as a regulator of postmitotic growth in germline nurse cells. In these latter cells, Cic-L behaves as a temporal signal that terminates endoreplicative growth before they dump their contents into the oocyte. We show that Cic-L is necessary and sufficient for nurse cell endoreplication arrest and induces both stabilization of CycE and down-regulation of Myc. Surprisingly, this function depends mainly on the Cic-L–specific N-terminal module, which is capable of acting independently of the Cic HMG-box–containing core. Mirroring these observations, basal metazoans possess truncated Cic-like proteins composed only of Cic-L N-terminal sequences, suggesting that this module plays unique, ancient roles unrelated to the canonical function of Cic., This work was funded by the Spanish Government (grants BFU2014-52863-P, BFU2017-87244-P, and PID2020-119248GB-I00), the Generalitat de Catalunya (Grant 2017 SGR 475), and the NIH (Grant GM141843). L.R.-M. and C.L. were supported by predoctoral contracts from the Spanish Government.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Maternal histone mRNAs are uniquely processed through polyadenylation in a Stem-Loop Binding Protein (SLBP) dependent manner

  • Pérez-Roldán, Juan
  • Henn, Laszlo
  • Bernués, Jordi
  • Torras-Llort, Mònica
  • Tamirisa, Srividya
  • Belloc, Eulàlia
  • Rodríguez-Muñoz, Laura
  • Timinszky, Gyula
  • Jiménez, Gerardo
  • Méndez, Raúl
  • Carbonell, Albert
  • Azorin, Fernando
During early embryogenesis the zygotic genome remains transcriptionally silent and expression relies on maternally deposited products. Maternal deposition of histones is crucial to preserve chromatin integrity during early embryo development, when the number of nuclei exponentially increases in the absence of zygotic expression. In the Drosophila embryo, histones are maternally deposited as both proteins and mRNAs. Histone transcripts are the only nonpolyadenylated cellular mRNAs. They contain a highly conserved 3′UTR stem-loop structure, which is recognized by the Stem-Loop Binding Protein (SLBP) that, in conjunction with U7 snRNP, regulates their unique 3′-end processing. Here we report that, unexpectedly, maternal histone mRNAs are polyadenylated and have a truncated 3′ stem-loop. This noncanonical 3′-end processing of maternal histone mRNAs occurs at their synthesis during oogenesis and requires SLBP, but not U7 snRNP. We show that maternal histone transcripts are subjected to cytoplasmic poly(A) tail elongation by Wisp, which results in their stabilization and is a requisite for translation. We also show that maternal histone transcripts remain largely quiescent and that their translation is activated upon loss of the embryonic linker histone dBigH1, which impairs chromatin assembly and induces DNA damage. Here, we discuss possible models to integrate these observations., This work was financed by grants PGC2018-094538-B-100, PID2020-119248GB-I00, and PID2021-123303NB-I00 from MICIN/AEI 10.13039/501100011033 and “FEDER, una manera de hacer Europa”, and of the Generalitat de Catalunya (SGR2017-475)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The repressor Capicua is a barrier to lung tumor development driven by Kras/Trp53 mutations

  • Ballesteros-González, Irene
  • Hernández-Navas, Iván
  • Brehey, Oksana
  • Lechuga, Carmen G.
  • Salmón, Marina
  • Scotece, Morena
  • Velasco-Vicente, Ricardo
  • Flores-Gómez, Alejandra A.
  • Cebriá, Antonio
  • Simón-Carrasco, Lucía
  • Jiménez, Gerardo
  • Musteanu, Monica
  • Guerra, Carmen
  • Domínguez, Orlando
  • Caleiras, Eduardo
  • Blanco-Aparicio, Carmen
  • Pons, Tirso
  • Ferrer, Irene
  • Paz-Ares, Luis
  • Torres-Ruiz, Raul
  • Rodríguez-Perales, Sandra
  • Barbacid, Mariano
  • Drosten, Matthias
KRAS mutations are responsible for a quarter of all lung adenocarcinomas. However, the molecular mechanisms linking these mutations and their frequent secondary dosage amplification to tumor formation are still not fully understood. While ample evidence supports a crucial role for the MAPK pathway in tumor development, the primary effectors targeted by this pathway remain largely unexplored. Here we identify the transcriptional repressor Capicua (CIC) as a key target inactivated by KRAS/MAPK signaling in lung adenocarcinoma. We show that genetic loss of CIC recapitulates the phenotypic consequences of amplified KRAS signaling. Genetic disruption of CIC suppressed the requirement for Kras allelic imbalances and accelerated the transformation of bronchiolar Club cells. We also demonstrate that restoring CIC repressor activity impaired proliferation of CIC-deficient tumor cells and reverted resistance to MAPK pathway inhibitors. These results highlight the key role of CIC during lung tumor formation and suggest that selective pressure for effective CIC inactivation favors secondary amplification of KRAS/MAPK signaling in tumor cells., This work was supported by a grant from the Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación (grant PID2020-116705RB-I00) to M.D. M.D. also received funding from the Scientific Foundation of the Spanish Association Against Cancer (grant LABAE211678DROS). This work was further supported by a grant from the Scientific Foundation of the Spanish Association Against Cancer (Programa Excelencia 2022 grant EPAEC222641CICS); grants from Instituto de Salud Carlos III, co-funded by FEDER (grants PI23/01932 and PI21/01641) and the Scientific Foundation of the Spanish Association Against Cancer (grant LABAE20049RODR) to S.R.-P.; as well as a grant from the Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación (grant PID2020-119248GB-I00) to G.J. T.P. was supported in part by a grant from the Comunidad de Madrid (grant P2022/BMD-7321/MITIC-CM). This work was also supported in part by grants from the European Research Council (ERC-AG/695566 [THERACAN]), the Comunidad de Madrid (B2017/BMD-3884 iLUNG-CM) and the Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación (RTI2018-094664-B-I00) to M.B. M.B. is a recipient of an Endowed Chair from the AXA Research Fund. O.B. was a recipient of a fellowship from the Formación de Personal Investigador (FPI) program of the Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación (PRE2019-091685). M.Salmón was supported by a predoctoral contract “Severo Ochoa” from the Formación de Personal Investigador (FPI) program of the Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación (BES-2016-079096). A.A.F.-G. was a recipient of a CONAHCYT fellowship from the Mexican Government. L.S.-C. was supported by a Postdoctoral Research Contract from the Scientific Foundation of the Spanish Association Against Cancer (POSTD211274SIMÓ)., Peer reviewed